Listar por Autor Dávila Saralegui, Belén
Mostrando resultados 1 a 7 de 7
| Fecha de publicación | Título | Autor(es) |
| 2022 | Development and evaluation of 2-amino-7-fluorophenazine 5,10-dioxide polymeric micelles as antitumoral agents for 4T1 breast cancer | Lecot Calandria, Nicole Valerie; Dávila Saralegui, Belén; Sánchez, Carina; Fernández Lomonaco, Marcelo Luis; González, Mercedes; Cabral González, Pablo; Cerecetto, Hugo |
| 2025 | Drug repurposing for Chagas disease: overcoming the hit-to-preclinical candidate stage | Veira, Claudia; Dávila Saralegui, Belén; Serna, Elva; Portillo, Nilda; Yaluff, Gloria; Álvarez, Guzmán; Cerecetto, Hugo; Aguilera, Elena |
| 2025 | Escaping from flatland: 3D carborane-based bioisosteres of Erlotinib as potential anticancer agents | Dávila Saralegui, Belén; Vignolo, Pablo; González Alayón, Ignacio Darwin; Lecot Calandria, Nicole Valerie; Bonanata, Jenner; García, María Fernanda; Echeverría, Gonzalo A.; Piro, Oscar E.; Cerecetto, Hugo; Couto, Marcos |
| 2019 | Estudio de la actividad antitumoral en modelo de tumor sólido de cáncer de mama murino del pro-fármaco selectivo en hipoxia N 5, N 10- dióxido de 2-amino-7(8)-fluorofenazina | Dávila Saralegui, Belén |
| 2023 | Preclinical studies and drug combination of low-cost molecules for Chagas disease | Aguilera, Elena; Sánchez, Carina; Cruces, María Eugenia; Dávila Saralegui, Belén; Minini Rivas, Lucía; Mosquillo, María Florencia; Pérez-Díaz, Leticia; Serna, Elva; Torres, Susana; Schini, Alicia; Sanabria, Luis; Vera de Bilbao, N.I.; Yaluff, Gloria; Zolessi, Flavio R.; Ceilas, Luis Fabian; Cerecetto, Hugo; Álvarez, Guzmán |
| 2025 | Structure-activity relationships of closo- and nido-carborane Erlotinib analogs: lipophilicity as a key modulator of anti-glioma activity | Dávila Saralegui, Belén; Vignolo, Pablo; Silvarrey, Martina; Benitez, Andrés; González Schmidt, Juliana; de Arteaga Guidotti, Carmela; García, María Fernanda; Cerecetto, Hugo; Couto, Marcos |
| 2020 | Sunitinib-containing carborane pharmacophore with the ability to inhibit tyrosine kinases receptors FLT3, KIT and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity | Alamón, Catalina; Dávila Saralegui, Belén; García Melián, María Fernanda; Sánchez, Carina; Kovacs, Mariángeles; Trias, Emiliano; Barbeito, Luis; Gabay, Martín; Zeineh, Nidal; Gavish, Moshe; Teixidor, Francesc; Viñas, Clara; Couto, Marcos; Cerecetto, Hugo |